AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05867225 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Laparoscopic hiatal hernia repair
Description: laparoscopic hiatal hernia repair has replaced the traditional laparotomic or thoracotomic approach, and has resulted in a reduction of length of hospital stay and morbidity, and increased patients' acceptance
Study NCT04696393 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitapivat tablet
Description: Oral tablets
Study NCT05801445 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Occupation-based activity
Description: Painting large-scale canvas
Study NCT05801445 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Body-Weight Exercise
Description: Body-weight exercises designed for older adults
Study NCT04996368 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tranexamic acid injection
Description: Randomized comparison of two doses of tranexamic acid as prophylactic before start of incision in open heart surgery use for prevention of bleeding.
Study NCT06546540 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Telitacicept
Description: 160mg，once weekly
Study NCT05037747 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Time-restricted feeding(TRF)
Description: The TRF group was asked to restrict the eating window to 8 hours a day, during waking hours and also continue a low-protein diet.
Study NCT06444490 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: General Approach Instruction
Description: Oral health instruction focused more broadly on the different topics of oral diseases and oral hygiene care.
Study NCT06444490 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Personalised Technique Instruction
Description: Oral health instruction based on the specific needs of each participant.
Study NCT05311722 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: Inj dexmedetomidine, will be given in infusion over 10 mins and their effect on post spinal shivering will be assessed.
Study NCT05311722 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine
Description: Ketamine
Study NCT05311722 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tramadol
Description: Tramadol
Study NCT06292390 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pet Therapy
Description: Pet therapy was applied to the individuals in the intervention group for 6 weeks in addition to their normal routine lives. This therapy was applied every 20 minutes, 2 days a week. Repeated measurements were made before therapy, at the end of therapy and 4 weeks after the end of therapy.
Study NCT05176366 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ExoFlo
Description: Intravenous administration of bone marrow mesenchymal stem cell derived extracellular vesicles
Study NCT05306249 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CBD LGP 50
Description: Patients will receive CBD LGP 50 at a dose of 1 mg/kg twice a day in the form of oil dispensed through a graduated pipette until the end of week 12.
Study NCT05964439 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HoloUS app for ultrasound visualization
Description: Study participants will wear HoloLens see-through glasses and use the HoloUS app for ultrasound visualization in the conduct of a vascular access procedure in a phantom.
Study NCT06262022 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: cold therapy
Description: A cold ice pack will be applied to the patient's knee for 20 minutes every hour for three days, starting after total knee arthroplasty.
Study NCT06427629 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Imaging of conjunctival goblet cell
Description: After instillation of moxifloxacin and illuminating with a 405nm light source using confocal fluorescence microscopy, conjunctival goblet cell imaging will be performed in patients with ocular surface disease and patients scheduled for ocular surgery without ocular surface disease
Study NCT05306249 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients will receive the MCT oil placebo without CBD until the end of week 12.
Study NCT04561986 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tocilizumab
Description: Tocilizumab is a recombinant humanized monoclonal antibody directed against the human interleukin-6 (IL-6) receptor
Study NCT04940364 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pozelimab
Description: Administered intravenous (IV) or subcutaneous (SC) per protocol
Study NCT04940364 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cemdisiran
Description: Administered SC per protocol
Study NCT05172492 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Endocare
Description: Endocare will be administred through a virtual reality headseat used one to twice a day.
Study NCT05172492 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Digital control
Description: Digital control will be administred through a virtual reality headseat used one to twice a day.
Study NCT05572892 — intervention group
Intervention type: OTHER
Intervention: FAC scale
Description: Measurement of walking dependency according to the FAC scale :~* in the first week after stroke (in neurology by physiotherapists),~* then at 6 weeks, 12 weeks and 6 months (by telephone).~Trunk Control Test score (in the first week after stroke, by physiotherapists).~MRC score of hip extension and hip flexion, knee flexion/extension, ankle plantar and dorsal flexion (in the first week after stroke, by physiotherapists).~PHQ-9 depression scale (at 6 weeks by phone).~Denutrition (weight loss between neurology weight and 6-week weight, BMI +/- albumin).~Other intercurrent medical problems (at each telephone interview).
Study NCT05253859 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: Registry study: No intervention
Study NCT04312932 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LCPUFA Oil Supplement
Description: 25 mg/kg, 50 mg/kg, or 75 mg/kg of GLA+EPA+DHA as Omega 3-6 oil to be administered twice per day by mouth for 90 days
Study NCT04312932 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Canola Oil Placebo
Description: Equal volume (25 mg/kg, 50 mg/kg, or 75 mg/kg) of placebo (canola) oil to be administered twice per day by mouth for 90 days
Study NCT05952947 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HRYZ-T101 Injection
Description: On day 1, the TCR-T cells will be administered intravenously.
Study NCT05952947 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine + Cyclophosphamide
Description: Fludarabine: 25mg/m²/day×3days; Cyclophosphamide: 250mg/m²/day×3 days
Study NCT05344677 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Trendelenburg Position
Description: Group 1 (trendlenburg position group) in which the women will be positioned in a Trendelenburg position (20 °) once fully awake and cooperative in the recovery room and will remain in this posture for the first 24 hrs postoperatively. The maximum time allowed in a straight-up position will be three 15-min intervals over a 24-h period.
Study NCT05344677 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Warm Pad Application
Description: • Group 2 (warm pad application group) in this group warm pad (38◦C -40◦C) will be applied on the shoulder after four hours postoperatively for a period of 5-10 minutes. Each woman will be asked to place heat pads when needed during the first 24 hours.
Study NCT05344677 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Deep Breathing Exercise
Description: • Group 3: (deep breathing group) the researcher will instruct women after the end of surgery and upon consciousness to take slowly deep breathing while observing her chest and hold her breath for about 5 seconds and then exhale slowly, repeating this deep breathing technique five times after full vigilance within the first 3 hours after surgery. Then, the process will be repeated 6, 12, and 24 h later. The patient will be instructed about this type of breathing before surgery by researchers.
Study NCT05893589 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: test group
Description: Women in the intervention group participated in face-to-face and virtual meetings based on social cognitive theory structures for 4 weeks
Study NCT06485570 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: creative drama training
Description: The trainings prepared by the researcher in line with the literature information on Environmental Theory, Self-Care Disability Theory and Adaptation Model will be carried out in 3 sessions with creative drama teaching method to the experimental group. The trainings will be planned in the classroom environment for 4 weeks and 2 lesson hours (100 minutes) for each session. At the end of the trainings, Knowledge Measurement Questionnaire and Perception of Nursing Profession Scale will be applied to the participants as a post-test to measure their level of knowledge about nursing theories. In the third stage of the study, semi-structured interviews will be conducted with the students from the experimental group after the applications in order to reveal the participants' views on teaching methods.
Study NCT06485570 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: control
Description: control group
Study NCT05992688 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sucrose sweetened beverage
Description: Children who habitually consume sugar (sucrose) - sweetened beverages who are randomized to this arm, will consume the study product for 8 to 12 weeks.
Study NCT05992688 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stevia sweetened beverages
Description: Children who habitually consume sugar (sucrose) - sweetened beverages who are randomized to this arm, will consume the study product for 8 to 12 weeks.
Study NCT05992688 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Calorie free flavored water beverage
Description: Children who habitually consume sugar (sucrose) - sweetened beverages who are randomized to this arm, will consume the study product for 8 to 12 weeks.
Study NCT06291129 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Periodontal therapy
Description: Supragingival scaling sessions were performed with ultrasonic scalers (Dabi Atlante, Rio de Janeiro, RJ, Brazil) to remove all calculus and biofilms, in addition to oral hygiene guidelines, including brushing technique and interdental cleaning with dental floss.
Study NCT04864145 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcatheter Aortic Valve Implantation
Description: The VitaFlow™ system (MicroPort®, Shanghai, China) was a novel TAVR system, which incorporates high-radial force and a double layer polyethylene terephthalate (PET) skirt to optimize frame geometry and minimize the risks of paravalvular leak (PVL). The VitaFlow™ transcatheter aortic valve is made of a self-expanding nitinol frame and tri-leaflet bovine pericardial valve.
Study NCT04864145 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Medical therapy
Description: Angiotensin-neprilysin inhibition (ARNI), diuretics, dihydropyridine calcium channel blocker, angiotensin-converting enzyme (ACE) inhibitors/angiotensin receptor blockers (ARBs) or beta blockers.
Study NCT06265324 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Angioplasty
Description: Drug-coated balloons angioplasty for treatment of de novo and in-stent restenosis lesions
Study NCT05406336 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Predicted uncontrolled BP status (yes/no) at follow up visit, derived using a machine learning algorithm
Description: The investigators have created a machine learning algorithm to predict uncontrolled blood pressure (BP) status (yes/no) at a follow up visit among adults with uncontrolled BP at their current visit. The investigators will determine whether adding this information to a vignette describing a patient will increase the likelihood that a clinician will intensify antihypertensive medication treatment.
Study NCT05428280 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiotherapy
Description: Conventional treatment consisted of Transcutaneous Electrical Nerve Stimulation and Progressive Back Strengthening Exercise
Study NCT05428280 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physiotherapy
Description: Conventional treatment consisted of Transcutaneous Electrical Nerve Stimulation and Progressive Back Strengthening Exercise
Study NCT05428280 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Muscle Energy technique
Description: Muscle Energy Technique (MET) is a technique that was developed in 1948 by Fred Mitchell, Sr, D.O\[1\]. It is a form of manual therapy, widely used in Osteopathy, that uses a muscle's own energy in the form of gentle isometric contractions to relax the muscles via autogenic or reciprocal inhibition and lengthen the muscle.
Study NCT05428280 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Myofacial mobilization
Description: It is a type of gentle, constant massage that releases tightness and pain throughout your myofascial tissues
Study NCT04740723 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: iRF System Renal Denervation
Description: The iRF System is a percutaneous, catheter-based device which uses RF energy to circumferentially denervate the sympathetic nerves surrounding the artery
Study NCT05488288 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Mesh repair
Description: Abdominal ventral hernia (VH) repair with mesh during bariatric surgery. the repair technique and the type of mesh are left to the choice of the center, as there are no strong data to demonstrate which technique is the best for VH repair in this population.
Study NCT05488288 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Suture repair
Description: The hernia sack is resected through an open approach, and the fascial defect is systematically closed with a slowly absorbable monofilament suture.
Study NCT04912154 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Rehabilitation protocol
Description: Rehabilitation protocol after open surgery for Achilles tendon rupture
Study NCT04912154 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Rehabilitation protocol
Description: Rehabilitation protocol after open surgery for Achilles tendon rupture
Study NCT04545528 — intervention group
Intervention type: BEHAVIORAL
Intervention: Dietary recommendations
Description: The test group will be seen by a nutritionist and will receive specific dietary recommendations according to their specific comorbidities and drugs
Study NCT04952480 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Dose-escalated adaptive radiotherapy
Description: Adaptive planning of Radiation Therapy with two re-plans of the treatment field through course of therapy with the shrinking treatment fields according to tumor response to escalate dose, as allowed by dose to organs-at-risk.
Study NCT04952480 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Description: Concurrent standard of care platinum doublet based therapy
Study NCT06164015 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 3D Ultrasound scan with power Doppler angiography
Description: The study group and the control group will be offered a 3D ultrasound scan as a part of this trial.
Study NCT06270277 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Pediatric Quality of Life Inventory (PedsQL)
Description: Questionnaire
Study NCT06270277 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Pediatric Quality of Life Inventory (PedsQL)
Description: Questionnaire
Study NCT06270277 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Strengths and Difficulties Questionnaire (SDQ)
Description: Questionnaire
Study NCT06270277 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Strengths and Difficulties Questionnaire (SDQ)
Description: Questionnaire
Study NCT04721366 — intervention group
Intervention type: OTHER
Intervention: Standard of Care
Description: Neonatal and pediatric participants who has been on ERT (VPRIV) will be assessed as per SOC.
Study NCT05366296 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: A Lyophilized COVID-19 mRNA Vaccine
Description: Active substance: NTD-RBD derived from S protein of Omicron variant Excipient: ALC-0315 (4- hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2- hexyldecanoate), ALC-0159 (2-\[(polyethylene glycol)-2000\]-N, N-ditetradecylacetamide), DSPC \[1,2- distearoyl-sn-glycero-3-phosphocholine\], Cholesterol, Trometamol and Sucrose
Study NCT05366296 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Normal saline (0.9% sodium chloride solution
Study NCT05693025 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group Exercise
Description: The study evaluates two different approaches for group exercise. Participants in the Standard Implementation (SI) group complete the standard Walk with Ease intervention as recommended by the Arthritis Foundation. Participants are guided to learn and perform a series of stretching and strengthening exercises recommended in the base WWE program. Primary BCTs include instruction on how to perform behavior (#4.1) and Graded tasks (#8.7). Participants in the Enhanced Implementation (SI) group complete the standard Walk with Ease intervention as recommended by the Arthritis Foundation. They may perform some of the same exercises as those in the SI group but they are also guided to learn and perform specific exercises prescribed by a physical therapist to improve balance and reduce risks of falling. The primary BCTs include instruction on how to perform behavior (#4.1), Graded tasks (#8.7) from the base program as well as Information on health consequences (#5.1) and Credible source (#9.1).
Study NCT06495593 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ocrelizumab
Description: Standard ocrelizumab dosing
Study NCT05693025 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Group Exercise
Description: The study evaluates two different approaches for group exercise. Participants in the Standard Implementation (SI) group complete the standard Walk with Ease intervention as recommended by the Arthritis Foundation. Participants are guided to learn and perform a series of stretching and strengthening exercises recommended in the base WWE program. Primary BCTs include instruction on how to perform behavior (#4.1) and Graded tasks (#8.7). Participants in the Enhanced Implementation (SI) group complete the standard Walk with Ease intervention as recommended by the Arthritis Foundation. They may perform some of the same exercises as those in the SI group but they are also guided to learn and perform specific exercises prescribed by a physical therapist to improve balance and reduce risks of falling. The primary BCTs include instruction on how to perform behavior (#4.1), Graded tasks (#8.7) from the base program as well as Information on health consequences (#5.1) and Credible source (#9.1).
Study NCT05693025 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Training
Description: The study evaluates two different approaches for promoting behavior change. Participants in the Standard Training (ST) model follow the standardized Walk with Ease training to support behavior change. Participants are provided with goal setting tools and an online tracker to monitor their progress. Weekly video-based lessons, resource links and eBook content support behavior change. Primary BCTs include Goal Setting (BCT #1.1) and self-monitoring (BCT#2.3). Participants in the Enhanced Training (ET) model access the same basic content as the ST model, but the weekly education-based videos are replaced with lessons focus on habit-formation training. Student coaches are also assigned to individual participants to support behavior change efforts using motivational interviewing strategies. Thus, participants in the ET model also receive two additional theory- and evidence-based BCTs: (1) habit formation training (BCT#1.2, #1.4, #8.3) and (2 health coaching (BCT# 3.3).
Study NCT05693025 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Behavioral Training
Description: The study evaluates two different approaches for promoting behavior change. Participants in the Standard Training (ST) model follow the standardized Walk with Ease training to support behavior change. Participants are provided with goal setting tools and an online tracker to monitor their progress. Weekly video-based lessons, resource links and eBook content support behavior change. Primary BCTs include Goal Setting (BCT #1.1) and self-monitoring (BCT#2.3). Participants in the Enhanced Training (ET) model access the same basic content as the ST model, but the weekly education-based videos are replaced with lessons focus on habit-formation training. Student coaches are also assigned to individual participants to support behavior change efforts using motivational interviewing strategies. Thus, participants in the ET model also receive two additional theory- and evidence-based BCTs: (1) habit formation training (BCT#1.2, #1.4, #8.3) and (2 health coaching (BCT# 3.3).
Study NCT05459558 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Experimental Dentifrice 1
Description: 5 percent (%) potassium nitrate (KNO3) dentifrice with 1% alumina and 5% sodium tripolyphosphate (STP).
Study NCT05459558 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Experimental Dentifrice 2
Description: 5% KNO3 dentifrice with 1% alumina, 5% STP and 2% high cleaning silica.
Study NCT05459558 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Reference Dentifrice
Description: Regular Fluoride Dentifrice.
Study NCT04750278 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FP-025 100 mg
Description: FP-025 100 mg BID
Study NCT04750278 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FP-025 300 mg
Description: FP-025 300 mg BID